Teva Pharmaceutical receives FDA approval for generic version of heartburn drug Prevacid

October 29th, 2009 more images more images AstraZeneca 3Q earns up 22 percent LONDON — Pharmaceutical company AstraZeneca PLC posted a 22 percent rise in third quarter net profit on Thursday, boosted by initial sales of its swine flu vaccine and delayed entry of generic drug competition in the United States. The expectation of further profits expected from its Novel Influenza A vaccine for the H1N1 led AstraZeneca to lift its full-year earnings forecast.

October 27th, 2009 more images more imagesChemotherapy drug sales boost Hospira 3Q profitLAKE FOREST, Ill. — Hospira Inc.

October 26th, 2009 Shire says FDA reaffirms Vyvanse exclusivityNEW YORK — Shire PLC said the U.S. Food and Drug Administration reaffirmed a prior decision to give the attention-deficit-hyperactivity disorder drug Vyvanse five-years of market exclusivity.

October 9th, 2009 J&J wheels and deals, awaits new product approvalsNEW BRUNSWICK, N.J. — Johnson & Johnson, the world's biggest healthcare company and a Dow Jones industrial average component, reports earnings for the third quarter Tuesday morning.

October 8th, 2009 WASHINGTON - A new study done by Israeli scientists has shown that heartburn drugs are safe for the foetus. The study, conducted by researchers at the Ben-Gurion University of the Negev, Israel, has been published in the Journal of Clinical Pharmacology.

September 29th, 2009 CHENNAI - Pharma major Wockhardt Tuesday got the US Food and Drug Administration's (USFDA) tentative approval for marketing Tamsulosin Hydrochloride capsules. Tamsulosin is being used for treating non-cancerous enlargement of prostate, technically called benign prostatic hyperplasia.

September 25th, 2009 European committee recommends Wyeth's Prevenar 13NEW YORK — Wyeth said Friday European Union regulators are recommending approval for a new version of its children's pneumococcal vaccine, Prevenar 13. The Madison, N.J., company said the Committee for Medicinal Products for Human Use recommended approval in children 6 weeks to 5 years to prevent pneumococcal disease, as well as pneumonia and middle ear infections caused by related strains of the bacterium.

September 25th, 2009 HYDERABAD - Union Minister of Commerce and Industry Anand Sharma today said that the exports of drugs, pharmaceuticals and fine chemicals for the year 2008-09 stood at Rs.39,538 crore, registering a growth of about 29 per cent over the last year. Addressing the Indo-Africa Pharma Business meet here, Sharma said: "In recent times, the Indian pharmaceutical sector has emerged as one of the major contributors to Indian exports with export earnings rising from a negligible amount in early 1990s to Rs.29,139.57 crore by 2007-08.

September 25th, 2009 CHENNAI - Decks have been cleared for the city-based Orchid Chemicals and Pharmaceuticals for marketing the generic versions of Zosyn antibiotic, with a US district court rejecting rival Wyeth Laboratories' motion for a restraint on the sale of the drug. Wyeth had filed a suit in the District Court of Columbia against the US Food and Drug Administration's (FDA) decision to grant Orchid permission to sell generic Zosyn, chemically Piperacillin-Tazobactam, claiming the drug could harm critically ill patients.

September 25th, 2009 Wyeth says committee recommends Prevenar-13 OKNEW YORK — Wyeth says European Union regulators are recommending approval for a new version of its children's pneumococcal vaccine, Prevenar 13. The Madison, N.J., company says the Committee for Medicinal Products for Human Use recommended approval in children 6 weeks to 5 years to prevent pneumococcal disease, as well as pneumonia and middle ear infections caused by related viruses.

September 24th, 2009 FDA panel backs reformulated OxyContin pillWASHINGTON — Federal health advisers on Thursday recommended approval for a new version of the painkiller OxyContin that is designed to be harder to abuse. A Food and Drug Administration panel of experts voted 14-4 in favor of the reformulated OxyContin from Purdue Pharma.

September 22nd, 2009 FDA: 'limited' benefit with tamper-proof OxyContinWASHINGTON — Federal health officials say a new version of the painkiller OxyContin that is designed to be harder to abuse offers some improvements over the original pill. Purdue Pharma LP has touted the new pill's plastic-like coating, which is designed to make the drug harder to crush and snort or inject.

September 10th, 2009 WASHINGTON - The largest ever study on 'Proton pump inhibitors' (PPI)-the second most prescribed group of drugs for heartburn-has dismissed all fears about the cancer causing effects of the treatment. PPI are the most commonly used treatment for chronic acid reflux, or 'heartburn', a painful burning sensation in the chest, neck and throat which is experienced by almost a third of people in developed countries.

September 5th, 2009 AHMEDABAD - Gujarat will set up state-of-the-art food and drug testing laboratories in Rajkot and Bhuj in the state's Saurashtra-Kutch region, Health Minister Jaynarayan Vyas said Saturday. "The state already has a modern food and drug testing laboratory at Vadodara.

August 28th, 2009 Watson gets approval for emergency contraceptiveCORONA, Calif. — Watson Pharmaceuticals Inc.